Lack of association between angiotensin-converting enzyme gene polymorphism and peripheral vascular disease in type 2 diabetic patients in Taiwan

Circulation Journal

Volumn 66, Issue 11, 2002, Pages 1014-1018

  Tseng, Chin Hsiao ^a   Tseng, Ching Ping ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Angiotensin converting enzyme; Gene polymorphism; Peripheral vascular disease; Risk factor; Type 2 diabetes mellitus

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE; GENETIC ASSOCIATION; HUMAN; INTRON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; POLYMERASE CHAIN REACTION; PREVALENCE; TAIWAN; ENZYMOLOGY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; MIDDLE AGED; RISK;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; PERIPHERAL VASCULAR DISEASES; POLYMORPHISM, GENETIC; TAIWAN;

EID: 0036858274     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.66.1014     Document Type: Article

References (32)

1. Tseng CH, Tai TY, Chen CJ, Lin BJ. Ten-year clinical analysis of diabetic leg amputees. J Formos Med Assoc 1994; 93: 388-392.
2. The Global Lower Extremity Amputation Study Group. Epidemiology of lower extremity amputation in centers in Europe, North America and East Asia. Br J Surg 2000; 87: 328-337.
3. Tseng CH, Tai TY, Chen CJ, Lin BJ. Mortality in diabetic patients after lower extremity amputations. J Formos Med Assoc 1994; 93: 842-848.
4. Tseng CH. Atherosclerotic vascular diseases and associated risk factors among diabetic patients in Taiwan. J Intern Med Taiwan 1999; 10: 93-98.
5. Butler R, Morris AD, Struthers AD. Angiotensin-converting enzyme gene polymorphism and cardiovascular disease. Clin Sci 1997; 93: 391-400.
6. Griendling KK, Murphy TJ, Alexander RW. Molecular biology of the renin-angiotensin system. Circulation 1993; 87: 1816-1828.
7. Kennon B, Petrie JR, Small M, Connell JMC. Angiotensin-converting enzyme gene and diabetes mellitus. Diabet Med 1999; 16: 448-458.
8. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin-II. J Clin Invest 1993; 91: 2268-2274.
9. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
10. Fujisawa T, Ikegami H, Kawaguchi Y, Hamada Y, Ueda H, Shintani M, et al. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 1998; 41: 47-53.
11. Missouris CG, Barley J, Jeffery S, Carter ND, Singer DR, MacGregor GA. Genetic risk for renal artery stenosis: Association with deletion polymorphism in angiotensin 1-converting enzyme gene. Kidney Int 1996; 49: 534-537.
12. Takezako T, Zhang B, Serikawa T, Fan P, Nomoto J, Saku K. The D allele of the angiotensin-converting enzyme gene and reperfusion-induced ventricular arrhythmias in patients with acute myocardial infarction. Jpn Circ J 2001; 65: 603-609.
13. Taniguchi I, Yamazaki T, Wagatsuma K, Kurusu T, Shimazu Y, Takikawa K, et al. The DD genotype of angiotensin converting enzyme polymorphism is a risk factor for coronary artery disease and coronary stent restenosis in Japanese patients. Jpn Circ J 2001; 65: 897-900.
14. Chiang FT, Lai ZP, Chern TH, Tseng CD, Hsu KL, Lo HM, et al. Lack of association between angiotensin-converting enzyme gene polymorphism and coronary heart disease in a Chinese population. Jpn Heart J 1997; 38: 227-236.
15. Chuang LM, Chiu KC, Chiang FT, Lee KC, Wu HP, Lin BJ, et al. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients with hypertension, non-insulin-dependent diabetes mellitus, and coronary heart disease in Taiwan. Metabolism 1997; 46: 1211-1214.
16. Lin JJ, Yueh KC, Ham HJ, Chang DC, Chang CY, Yeh YH. Lack of association between deletion polymorphism of the ACE gene and ischemic vascular diseases in a Chinese population in Taiwan. Chung Hua I Hsueh Tsa Chih (Taipei) 1999; 62: 756-763.
17. Hsieh MC, Lin SR, Hsieh TJ, Hsu CH, Chen HC, Shin SJ, et al. Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan. Nephrol Dial Transplant 2000; 15: 1008-1013.
18. Tseng CH, Chong CK, Chen CJ, Tai TY. Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis 1996; 120: 125-133.
19. Tseng CH, Chong CK, Chen CJ, Tai TY. Lipid profile and peripheral vascular disease in arseniasis-hyperendemic villages in Taiwan. Angiology 1997; 48: 321-335.
20. Tseng CH, Chen CJ, Lin BJ, Tai TY. Abnormal response of ankle pressure after exercise in seemingly normal subjects living in blackfoot disease-hyperendemic villages in Taiwan. Vasc Surg 1994; 28: 607-617.
21. Lin MH, Tseng CH, Tseng CC, Huang CH, Chong CK, Tseng CP. Real-time PCR for rapid genotyping of angiotensin-converting enzyme insertion/deletion polymorphism. Clin Biochem 2001; 34: 661-666.
22. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995; 332: 706-711.
23. Sanderson JE, Young RP, Yu CM, Chan S, Critchley JAJH, Woo KS. Lack of association between insertion/deletion polymorphism of the angiotensin-converting enzyme gene and end-stage heart failure due to ischaemic or idiopathic dilated cardiomyopathy in the Chinese. Am J Cardiol 1996; 77: 1008-1010.
24. Hunley TE, Julian BA, Philips JA, Summar ML, Yoshida H, Horn RG, et al. Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 1996; 49: 571-577.
25. Rosatto N, Pontremoli R, De Ferrari G, Ravazzolo R. Intron 16 insertion of the angiotensin converting enzyme gene and transcriptional regulation. Nephrol Dial Transplant 1999; 14: 868-871.
26. Bloem LJ, Manatunga AK, Pratt JH. Racial differences in the relationship of an angiotensin-converting enzyme gene polymorphism to serum angiotensin-converting enzyme activity. Hypertension 1996; 27: 62-66.
27. Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995; 345: 1600-1603.
28. Fogarty DG, Harron JC, Hughes AE, Nevin NC, Doherty CC, Maxwell AP. A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 1996; 45: 1204-1208.
29. Doria A, Onuma T, Warram JH, Krolewski AS. Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM. Diabetologia 1997; 40: 1293-1299.
30. Tiret L, Bonnardeaux A, Poirier O, Richard S, Marques-Vidal P, Evans A, et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphism on risk of myocardial infarction. Lancet 1994; 344: 910-913.
31. Taute BM, Handschug K, Taute R, Seifert H, Glaser C, Podhaisky H. Angiotensin-converting enzyme gene insertion/deletion polymorphism and peripheral arterial occlusive disease. Vasa 1998; 27: 149-153.
32. Tseng CH, Chong CK, Lin BJ, Chen CJ, Tai TY. Atherosclerotic risk factors for peripheral vascular disease in non-insulin-dependent diabetic patients. J Formos Med Assoc 1994; 93: 663-667.